Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT02428309Phase 1Terminated
Autologous Polyclonal Tregs for Lupus
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic
StudychairStart date: 2015-08-27

Research Network

Collaboration Network

13 collaborators·18 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, San Francisco

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Bluestone, PhD

University of California, San Francisco

Moderately Similar
3 trials

Shared therapeutic areas:

Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic

Worked with same sponsors:

Autoimmunity Centers of ExcellenceNational Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score34%

Maria Dall'Era, MD

University of California, San Francisco

Moderately Similar
2 trials

Shared therapeutic areas:

Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic

Worked with same sponsors:

Autoimmunity Centers of ExcellenceNational Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score34%

David Wofsy, MD

University of California, San Francisco

Moderately Similar
3 trials

Shared therapeutic areas:

Lupus Erythematosus, SystemicLupus Erythematosus, CutaneousLupus Erythematosus, Discoid

Worked with same sponsors:

Autoimmunity Centers of ExcellenceNational Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score34%

Michael Rosenblum, MD, PhD

University of California, San Francisco

Moderately Similar
1 trials

Shared therapeutic areas:

Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic

Worked with same sponsors:

Autoimmunity Centers of ExcellenceNational Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score34%

Xianyun Wang, Doctor

The First Hospital of Hebei Medical University

Related
4 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score10%

Qiubai Li, Professor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
7 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score10%

Veronique Leguern, MD

Service de Médecine Interne, Hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75679 PARIS Cedex 14.

Related
1 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score10%

Luc Mouthon, MD

Service de Médecine Interne, Hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75679 PARIS Cedex 14. Email: luc.mouthon@cch.aphp.fr

Related
1 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score10%

Colleen Annesley, MD

Seattle Children's Hospital

Related
7 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02428309Phase 1StudyChair

Autologous Polyclonal Tregs for Lupus

Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic
Terminated

All 1 trials loaded